Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to chronic pain and to post-surgical rehabilitation.

Hinge Health initially aimed to sell nearly 14 million shares in a $28-$32 range, with final pricing set at the higher end of the range. With some 8.5 million shares sold by the business, gross process from the offering are pegged at $272 million.

As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.

Stock futures traded slightly lower Friday and the S&P 500, down for three straight sessions, limped into the Memorial Day weekend.These stocks were poised to make moves Friday:Tesla rose 1.2% in premarket trading.

Deckers Outdoor (DECK) gave a lower-than-expected outlook for the current quarter, sending shares lower 13%. Ross Stores (ROSS) shares fell 11% afterhours following the

Initial public offerings from Hinge Health Inc. and MNTN Inc. both priced at the top of their estimated ranges in a bullish sign for the two deals, as the market for initial public offerings continues to gear up after an absence of deals in recent weeks.

The World Health Organization adopted a pandemic preparedness treaty, but the absence of the U.S. questions its efficacy. Texas reports a rise in measles cases, and digital health startup Hinge Health raises $437.